After the hindrance imposed by the COVID-19 pandemic, neuroscience research pushed forward. NeuroFrance 2023 took place as an in-person meeting and highlighted current and future strategies for exploring the brain and its pathologies, including a strong pathway to mental health research.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$59.00 per year
only $4.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rolland, T. et al. Nat. Med. 29, 1671–1680 (2023).
Khona, M. & Fiete, I. R. Nat. Rev. Neurosci. 23, 744–766 (2022).
Vanderhaeghen, P. & Polleux, F. Nat. Rev. Neurosci. 24, 213–232 (2023).
Abrous, D. N. et al. Mol. Psychiatry 27, 383–402 (2022).
Tamouza, R. et al. Transl. Psychiatry 13, 272 (2023).
Chachlaki, K. et al. Sci. Transl. Med. 14, 665 (2022).
Philippe, C. et al. Microorganisms 9, 716 (2021).
Bermudez-Martin, P. et al. Microbiome 9, 157 (2021).
Gauld, C. et al. J. Psychiatr. Res. 142, 153–159 (2021).
Melzi, S. et al. Brain Pathol. 32, e13027 (2022).
Spira, A. P. et al. JAMA Neurol. 70, 1537–1543 (2013).
André, C. et al. Ann. Neurol. 93, 979–990 (2023).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Dallérac, G., Rancillac, A. NeuroFrance 2023 — from basic neuroscience to translational discoveries. Nat. Mental Health 1, 824–826 (2023). https://doi.org/10.1038/s44220-023-00136-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s44220-023-00136-7